causal

Argenx blocks antibody recycling to clear autoantibodies

Argenx's drugs target the biological pathway that recycles pathogenic autoantibodies; blocking that recycling lets the harmful antibodies leave the system, so there is nothing left to attack healthy cells.

causalpending

Speaker

Julia

Evidence Quote

“when we block that passage of recycling, then those antibodies just get out of the system”

Source

Argenx: Changing Lives with Llamas— Business Breakdowns
Created: 11/17/2026, 3:39:21 AM

Your notes

Loading notes...